Todd A. Gillespie

2.1k total citations
34 papers, 1.7k citations indexed

About

Todd A. Gillespie is a scholar working on Spectroscopy, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Todd A. Gillespie has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Spectroscopy, 9 papers in Pharmacology and 9 papers in Psychiatry and Mental health. Recurrent topics in Todd A. Gillespie's work include Mass Spectrometry Techniques and Applications (10 papers), Analytical Chemistry and Chromatography (8 papers) and Schizophrenia research and treatment (7 papers). Todd A. Gillespie is often cited by papers focused on Mass Spectrometry Techniques and Applications (10 papers), Analytical Chemistry and Chromatography (8 papers) and Schizophrenia research and treatment (7 papers). Todd A. Gillespie collaborates with scholars based in United States, France and Japan. Todd A. Gillespie's co-authors include Richard M. Caprioli, Malin Andersson, Anthony Murphy, John T. Catlow, Kelem Kassahun, Edward L. Mattiuz, Steven Wrighton, Barbara J. Ring, R. Clark Lantz and Atsushi Kurihara and has published in prestigious journals such as Analytical Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

Todd A. Gillespie

34 papers receiving 1.6k citations

Peers

Todd A. Gillespie

SPECT

PMH

PHARM

D.D. Breimer Netherlands

Klaus D. Haegele United States

L. P. Balant Switzerland

Gordon McKay Canada

Ronald B. Franklin United States

Kazunobu Sugawara Japan

Ramakrishna Nirogi India

Geert Mannens Belgium

James A. Eckstein United States

James A. Yergey United States

D.D. Breimer Netherlands

Todd A. Gillespie

240 ×0.4

SPECT

334 ×0.7

231 ×0.6

PMH

501 ×1.4

PHARM

510 ×1.4

PHARM

Citations per year, relative to Todd A. Gillespie Todd A. Gillespie (= 1×) peers D.D. Breimer

Countries citing papers authored by Todd A. Gillespie

Since Specialization

Citations

This map shows the geographic impact of Todd A. Gillespie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd A. Gillespie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd A. Gillespie more than expected).

Fields of papers citing papers by Todd A. Gillespie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd A. Gillespie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd A. Gillespie. The network helps show where Todd A. Gillespie may publish in the future.

Co-authorship network of co-authors of Todd A. Gillespie

This figure shows the co-authorship network connecting the top 25 collaborators of Todd A. Gillespie. A scholar is included among the top collaborators of Todd A. Gillespie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd A. Gillespie. Todd A. Gillespie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gillespie, Todd A. & Brian E. Winger. (2010). Mass spectrometry for small molecule pharmaceutical product development: A review. Mass Spectrometry Reviews. 30(3). 479–490. 20 indexed citations

Smith, Richard L., et al.. (2007). Disposition and metabolic fate of prasugrel in mice, rats, and dogs. Xenobiotica. 37(8). 884–901. 20 indexed citations

Farid, Nagy A., et al.. (2007). The Disposition of Prasugrel, a Novel Thienopyridine, in Humans. Drug Metabolism and Disposition. 35(7). 1096–1104. 171 indexed citations

Yi, Ping, et al.. (2006). The Disposition and Metabolism of Naveglitazar, a Peroxisome Proliferator-Activated Receptor α-γ Dual, γ-Dominant Agonist in Mice, Rats, and Monkeys. Drug Metabolism and Disposition. 35(1). 51–61. 10 indexed citations

Zmijewski, Milton J., et al.. (2006). APPLICATION OF BIOCATALYSIS TO DRUG METABOLISM: PREPARATION OF MAMMALIAN METABOLITES OF A BIARYL-BIS-SULFONAMIDE AMPA (α-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID) RECEPTOR POTENTIATOR USING Actinoplanes missouriensis. Drug Metabolism and Disposition. 34(6). 925–931. 7 indexed citations

Wickremsinhe, Enaksha, Gurkeerat Singh, Bradley L. Ackermann, Todd A. Gillespie, & Ajai K. Chaudhary. (2006). A Review of Nanoelectrospray Ionization Applications for Drug Metabolism and Pharmacokinetics. Current Drug Metabolism. 7(8). 913–928. 44 indexed citations

Thalamas, Claire, Iris Rajman, Jaime Kulisevsky, et al.. (2005). Pergolide. Clinical Neuropharmacology. 28(3). 120–125. 12 indexed citations

Gillespie, Todd A., P Kulanthaivel, R. Clark Lantz, et al.. (2004). Synthesis and biological activity of some known and putative duloxetine metabolites. Bioorganic & Medicinal Chemistry Letters. 14(13). 3481–3486. 34 indexed citations

Wheeler, William J., et al.. (2004). The synthesis of (S)‐di‐n‐propyl‐(8‐isoxazol‐5‐yl‐1,2,3,4‐tetrahydronaphthalen‐2‐yl)amine hydrochloride and its C‐14‐labeled isotopomer. Journal of Labelled Compounds and Radiopharmaceuticals. 48(2). 149–164. 4 indexed citations

10.

Lantz, R. Clark, et al.. (2003). METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS. Drug Metabolism and Disposition. 31(9). 1142–1150. 173 indexed citations

11.

Murphy, Anthony, et al.. (1998). Characterization of olanzapine (LY170053) in human liver slices by liquid chromatography/tandem mass spectrometry. Journal of Mass Spectrometry. 33(12). 1237–1245. 12 indexed citations

12.

Ackermann, Brad, et al.. (1996). Application of Packed Capillary Liquid Chromatography/Mass Spectrometry with Electrospray Ionization to the Study of the Human Biotransformation of the Anti-emetic Drug Dolasetron. Journal of Mass Spectrometry. 31(6). 681–689. 9 indexed citations

13.

Ring, Barbara J., John T. Catlow, Thomas J. Lindsay, et al.. (1996). Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.. Journal of Pharmacology and Experimental Therapeutics. 276(2). 658–666. 170 indexed citations

14.

Gillespie, Todd A., et al.. (1995). Determination of the muscarinic agent [(3-(3-1-butylthio)-1,2,5-thiadiazol-4-yl)-1-azabicyclo[2.2.2]octane], in rat, rabbit, and monkey plasma, using high-performance liquid chromatography in conjunction with tandem mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 673(1). 67–74. 1 indexed citations

15.

Murphy, Anthony, et al.. (1995). Determination of xanomeline and active metabolite, N-desmethylxanomeline, in human plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 668(2). 273–280. 16 indexed citations

16.

Catlow, John T., et al.. (1995). Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 668(1). 85–90. 95 indexed citations

17.

Murphy, Anthony, et al.. (1994). Determination of xanomeline in human plasma by ionspray tandem mass spectrometry. Journal of Mass Spectrometry. 23(10). 621–625. 22 indexed citations

18.

Boxenbaum, Harold, et al.. (1993). Human dolasetron pharmacokinetics: II Absorption and disposition following single‐dose oral administration to normal male subjects. Biopharmaceutics & Drug Disposition. 14(2). 131–141. 29 indexed citations

19.

Boxenbaum, Harold, et al.. (1992). Human dolasetron pharmacokinetics: I. Disposition following single‐dose intravenous administration to normal male subjects. Biopharmaceutics & Drug Disposition. 13(9). 693–701. 50 indexed citations

20.

Berkson, Earl, et al.. (1983). Spectral Families of Projections, Semigroups, and Differential Operators. Transactions of the American Mathematical Society. 275(2). 431–431. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact